Apyx Medical Corporation

NASDAQ: APYX · Real-Time Price · USD
2.17
0.05 (2.36%)
At close: Aug 15, 2025, 12:07 PM

Apyx Medical Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
31.74M 43.65M 10.19M 30.87M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
1.66M 1.73M 1.22M 1.11M
Receivables
15.48M 14.05M 18.25M 21.16M
Inventory
7.56M 9.92M 11.8M 6.78M
Other Current Assets
1.66M 2.73M 2.74M n/a
Total Current Assets
56.44M 70.36M 42.97M 60.74M
Property-Plant & Equipment
6.74M 7.15M 7.59M 6.87M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
8.4M 8.88M 8.8M 7.98M
Total Assets
64.84M 79.24M 51.77M 68.72M
Account Payables
2.62M 2.71M 2.67M 2.63M
Deferred Revenue
n/a 488K 853K 533K
Short-Term Debt
355K 367K 253K 287K
Other Current Liabilities
5.42M 4.94M -253K 4.12M
Total Current Liabilities
10.72M 12.74M 11.85M 13.21M
Long-Term Debt
33.89M 33.19M n/a n/a
Other Long-Term Liabilities
259K 198K 181K 166K
Total Long-Term Liabilities
39.79M 39.58M 2.13M 1.51M
Total Liabilities
50.51M 52.32M 13.98M 14.71M
Total Debt
38.76M 38.5M 796K 305K
Common Stock
38K 35K 35K 34K
Retained Earnings
-77.91M -54.45M -35.73M -12.55M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
14.21M 26.7M 37.58M 53.7M
Total Investments
n/a n/a n/a n/a